Testing effectiveness (Phase 2)Study completedNCT00061425What this trial is testingTreatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgGWho this might be right forNon-Hodgkin's LymphomaLymphoma, B-Cell Gilead Sciences
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00098891What this trial is testingMS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more National Cancer Institute (NCI) 24
Early research (Phase 1)Not Yet RecruitingNCT07334574What this trial is testingClinical Study of XP-006 mRNA Vaccine for R/R B-NHLWho this might be right forB-cell Non-Hodgkin's Lymphoma (B-NHL) Ruijin Hospital 20
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Early research (Phase 1)Looking for participantsNCT06393738What this trial is testingARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Who this might be right forRelapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL) Arvinas Inc. 329
Testing effectiveness (Phase 2)Looking for participantsNCT05031897What this trial is testingTwo Step Haplo With Radiation ConditioningWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdult T-Cell Leukemia/Lymphoma+14 more Thomas Jefferson University 63
Testing effectiveness (Phase 2)Ended earlyNCT03488251What this trial is testingPK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's LymphomaWho this might be right forNon-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma Molecular Templates, Inc. 8
Early research (Phase 1)Temporarily pausedNCT04746131What this trial is testingSafety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)Who this might be right forB-cell Non-Hodgkin's Lymphoma ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT05338931What this trial is testingSafety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forB-cell Non Hodgkin Lymphoma AbClon 82
Early research (Phase 1)Study completedNCT00005639What this trial is testingAzacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Early research (Phase 1)Active Not RecruitingNCT02732275What this trial is testingDS-3201b in Participants With LymphomasWho this might be right forLymphoma, MalignantNon-hodgkin Lymphoma Daiichi Sankyo Co., Ltd. 100
Early research (Phase 1)Study completedNCT00005988What this trial is testingBone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT00295880What this trial is testingDonor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+1 more Masonic Cancer Center, University of Minnesota 12
Very early researchUnknownNCT05444322What this trial is testingRD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomaWho this might be right forMantle Cell LymphomaDiffuse Large B-cell LymphomaFollicular Lymphoma He Huang 18
Large-scale testing (Phase 3)Study completedNCT00265837What this trial is testingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Early research (Phase 1)UnknownNCT06364852What this trial is testingAn Evaluation of LY007 Cell Injection for r/r B-NHLWho this might be right forB-NHL Ruijin Hospital 18
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Not applicableStudy completedNCT05927558What this trial is testingSalvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL StudyWho this might be right forB-cell Non Hodgkin LymphomaRelapseRefractory Lymphoma Gruppo Italiano Malattie EMatologiche dell'Adulto 59
Not applicableStudy completedNCT00547196What this trial is testingAlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & DisordersWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes City of Hope Medical Center 10